ASX:AC8

AusCann Group (AC8) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
537,446 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.79%
Price Target
N/A

About AusCann Group

AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia.

AC8 Stock News Headlines

Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
AC8.AX - AusCann Group Holdings Ltd
ACNNF AusCann Group Holdings Ltd
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
ASX pot stock update: What you need to know
AusCann Group Holdings Ltd.
See More Headlines
Receive AC8 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AusCann Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-10,700,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.55 million
Book Value
A$0.02 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.73
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Christopher Mews A.C.I.S.
    B. Bus, C.P.A., Chief Financial Officer
  • Ms. Rachel Jelleff Kerr
    Company Secretary

AC8 Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of AusCann Group own?
This page (ASX:AC8) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners